Clinical and Molecular Study of CHARGE Syndrom

Sponsor
Poitiers University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT03186144
Collaborator
(none)
141
1
1
46
3.1

Study Details

Study Description

Brief Summary

  1. Clinical description of a French cohort of patients with CHARGE syndrome.

  2. Search any phenotype-genotype correlation in typical, atypical or incomplete form of the syndrome

  3. Using Next generation Sequencing, try to identify other genes involved in this syndrome, as the CHD7 gene is involved in only 40-60% of cases

Condition or Disease Intervention/Treatment Phase
  • Genetic: Blodd punction for genetic analysis
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
141 participants
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Actual Study Start Date :
Feb 1, 2012
Actual Primary Completion Date :
Apr 1, 2015
Actual Study Completion Date :
Dec 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: No arm : descriptive study

Genetic: Blodd punction for genetic analysis

Outcome Measures

Primary Outcome Measures

  1. Description Clinical and molecular analysis of a French cohort CHARGE [12 month]

  2. Execution of the socio-adaptive scale, parental scale [12 month]

  3. Rate of mutations of CHD7 and / or type of mutations [12 month]

  4. analysis CHD7 gene from the patient's DNA [12 month]

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No

Inclusion Criteria: Clinical criteria

Major criteria:
  • Ocular coloboma

  • Chonamal atresia and/or cleft palate

  • Semi-CircularCanals hypoplasia

Minor criteria:
  • Cranial nerves

  • Hypothalamic-pituitary deficiency

  • Internal or external ear malformation

  • Cardiac, esophageal malformations

  • Intellectual Deficiency

Diagnosis criteria:
  • Typical CHARGE: 3 major criteria or 2 major + 2 minor

  • Partial CHARGE: 2 major + 1 minor

  • Atypical CHARGE: 2 major without minor or 1 major + 2 minor

Exclusion Criteria:
  • Absent consentment for genetic analysis

Contacts and Locations

Locations

Site City State Country Postal Code
1 French Referent centers for developement abnomalies Poitiers France 86000

Sponsors and Collaborators

  • Poitiers University Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Poitiers University Hospital
ClinicalTrials.gov Identifier:
NCT03186144
Other Study ID Numbers:
  • CHARGE
First Posted:
Jun 14, 2017
Last Update Posted:
Jun 14, 2017
Last Verified:
Jun 1, 2017

Study Results

No Results Posted as of Jun 14, 2017